Skip to content

Clinical trials

Hypertension trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Australia Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20043
20062
20073
20085
20094
20112
20129
20133
20146
20156
20161
20171
20183
20192
20201
20216
20224
20235
20246
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated12
Recruiting8
Unknown status6
Active, not recruiting4
Not yet recruiting2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The George Institute8
Medtronic Vascular7
AstraZeneca5
Baker Heart and Diabetes Institute5
Boehringer Ingelheim5
Novartis Pharmaceuticals4
Abbott Medical Devices3
Kona Medical Inc.3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Alnylam Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension87
Cardiovascular Diseases15
Renal Insufficiency, Chronic9
Vascular Diseases8
Stroke6
Cerebral Hemorrhage4
Diabetes Mellitus4
Pulmonary Arterial Hypertension4
Hypertension, Pulmonary3
Acute Coronary Syndrome2

Trials

Showing 51 to 75 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.